HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
31 hedge funds and large institutions have $9.74M invested in Hepion Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-8
Holders Change %
-20.51%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
9
Closed
10
Calls
$678K
Puts
$56K
Net Calls
+$622K
Net Calls Change
+$199K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$98.8K |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$37.4K |
| 3 |
State Street
Boston,
Massachusetts
|
+$33.5K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$10.3K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$10K |
